Stay updated with breaking news from Nautilus platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Standard BioTools (NASDAQ:LAB – Get Rating) and Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Earnings & Valuation This table compares Standard BioTools and […] ....
Susquehanna International Group LLP cut its holdings in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) by 35.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,818 shares of the company’s stock after selling 13,352 shares during the […] ....
Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) saw a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 469,300 shares, a decline of 49.7% from the March 15th total of 932,300 shares. Based on an average trading volume of 125,900 shares, the days-to-cover ratio is […] ....
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Nautilus Biotechnology to similar businesses based on the strength of its earnings, institutional ownership, valuation, analyst recommendations, dividends, profitability and risk. Institutional & Insider Ownership […] ....
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Nautilus Biotechnology to related companies based on the strength of its profitability, earnings, analyst recommendations, valuation, dividends, risk and institutional ownership. Earnings and Valuation This table compares […] ....